Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial.
J Neurosurg Spine
; 30(2): 222-227, 2018 11 09.
Article
en En
| MEDLINE
| ID: mdl-30497132
Palabras clave
BMI = body mass index; CCI = Charlson Comorbidity Index; DEPO = depomedrol; LOS = length of hospital stay; MCID = minimum clinically important difference; MIS TLIF = minimally invasive transforaminal lumbar interbody fusion; NODEPO = no depomedrol; ODI = Oswestry Disability Index; OME = oral morphine equivalent; POD = postoperative day; PROs = patient-reported outcomes; VAS = visual analog scale; depomedrol; intraoperative steroid; minimally invasive transforaminal lumbar interbody fusion; narcotics; postoperative pain
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Espondilolistesis
/
Degeneración del Disco Intervertebral
/
Vértebras Lumbares
/
Región Lumbosacra
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Aspecto:
Patient_preference
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Neurosurg Spine
Asunto de la revista:
NEUROCIRURGIA
Año:
2018
Tipo del documento:
Article
Pais de publicación:
Estados Unidos